What does ADARx Pharmaceuticals, Inc. do?
ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases. The company offers hepatic-targeted programs, including Agazisiran, a complement factor B (CFB) program that represents a pipeline-in-a-product…
What is ADARx Pharmaceuticals, Inc.'s P/E and P/B ratio?
ADARx Pharmaceuticals, Inc. has a P/E ratio of -15.2 and a P/B ratio of -7.52.
What is ADARx Pharmaceuticals, Inc.'s debt-to-equity ratio?
ADARx Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.06.
How much does ADARx Pharmaceuticals, Inc. owe compared with what it owns?
ADARx Pharmaceuticals, Inc. owes $1.55 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is ADARx Pharmaceuticals, Inc.'s Positivity rank?
ADARx Pharmaceuticals, Inc. is ranked #6,507 of 6,774 companies globally and #3,756 of 4,000 in United States on PositoAI, with a Positivity Score of -21,978.
Does ADARx Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for ADARx Pharmaceuticals, Inc..
Where can I read the latest news about ADARx Pharmaceuticals, Inc.?
Recent headlines about ADARx Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does ADARx Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of ADARx Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.